Showing results (1-10 of 432) with videos related to
Sort By:
Pageof 44
Emerging Infectious Diseases|January 23, 2019
International Biological Reference Preparations for Epidemic Infectious DiseasesTommy Rampling, Mark Page, Peter HorbyClinical Medicine (London, England)|March 16, 2019
Imported malaria: key messages in an era of eliminationTommy Rampling, Colin J Sutherland, Christopher Jm WhittyClinical Therapeutics|December 24, 2023
Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility StudyJames Lok, Maria Fernanda Guerra Veloz, Ruth Byrne, et al.BMJ Case Reports|March 16, 2021
Treating the treatment: chemotherapy-induced multi-organ toxicitySara Tyebally, Aderonke Abiodun, Sarah Slater, et al.Journal of Medical Microbiology|May 7, 2026
Clinician perspectives on patient consent for metagenomic next-generation sequencing of blood samples for the diagnosis of infection in clinical practiceTom G S Williams, Helen Umpleby, Temitope Fisayo, et al.Case Reports in Infectious Diseases|June 15, 2026
A Case of Cowpox Presenting as Progressive Unilateral Facial Swelling and Fever Without Any Skin LesionsOliver T R Toovey, Simon C Wooding, Amy Belfield, et al.European Cardiology|June 15, 2022
Chest Pain in the Cancer PatientSara Tyebally, Aruni Ghose, Daniel H Chen, et al.Therapeutic Advances in Gastroenterology|July 24, 2018
Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidenceRuth Byrne, Ivana Carey, Kosh AgarwalBMJ Case Reports|February 22, 2023
Acute Charcot arthropathy as a first presentation of type 2 diabetes mellitusRuth Byrne, Hannah Forde, Diarmuid SmithVaccines|August 2, 2018
Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical TrialsGeorgina Bowyer, Tommy Rampling, Jonathan Powlson, et al.Pageof 44